We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+37.58%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$10.5B
AUM Growth
+$2.1B
Cap. Flow
-$429M
Cap. Flow %
-4.09%
Top 10 Hldgs %
13.09%
Holding
245
New
23
Increased
75
Reduced
125
Closed
18

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$64.1M
2
BILL icon
BILL Holdings
BILL
+$53.1M
3
IMMU
Immunomedics Inc
IMMU
+$52.9M
4
ATRC icon
AtriCure
ATRC
+$51.2M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$49.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$120M
2
CBRE icon
CBRE Group
CBRE
+$89.6M
3
CHGG icon
Chegg
CHGG
+$66M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.2M
5
DOX icon
Amdocs
DOX
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 31.1%
2 Healthcare 19.47%
3 Industrials 14.73%
4 Consumer Discretionary 9.8%
5 Financials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPM icon
26
RPM International
RPM
$12.9B
$86.9M 0.83%
1,158,100
-136,005
-11% -$9.45M
WNS
27
DELISTED
WNS Holdings
WNS
$86.7M 0.83%
1,577,305
+93,520
+6% +$4.46M
ORLY icon
28
O'Reilly Automotive
ORLY
$70.6B
$86.4M 0.82%
3,074,625
-333,870
-10% -$8.73M
LFUS icon
29
Littelfuse
LFUS
$10.1B
$86M 0.82%
503,870
-132,445
-21% -$20.1M
EHC icon
30
Encompass Health
EHC
$12.1B
$84.9M 0.81%
1,724,202
-28,370
-2% -$1.53M
ENTG icon
31
Entegris
ENTG
$19.6B
$84M 0.8%
1,422,800
-191,200
-12% -$10.6M
TNDM icon
32
Tandem Diabetes Care
TNDM
$1.17B
$82.7M 0.79%
836,445
-40,130
-5% -$3.2M
CHE icon
33
Chemed
CHE
$6.72B
$81.9M 0.78%
181,540
-8,225
-4% -$3.67M
LHCG
34
DELISTED
LHC Group LLC
LHCG
$81.7M 0.78%
468,775
+95,634
+26% +$14M
CTLT
35
DELISTED
CATALENT, INC.
CTLT
$80.5M 0.77%
1,098,600
-430,975
-28% -$29.3M
GBT
36
DELISTED
Global Blood Therapeutics, Inc.
GBT
$79.8M 0.76%
1,263,710
+716,460
+131% +$49.1M
BC icon
37
Brunswick
BC
$4.54B
$78M 0.74%
1,219,200
-64,200
-5% -$3.2M
DPZ icon
38
Domino's
DPZ
$10.7B
$77.2M 0.74%
208,900
+23,300
+13% +$8.58M
ESTC icon
39
Elastic
ESTC
$8.94B
$77M 0.73%
835,100
-70,900
-8% -$5.18M
COUP
40
DELISTED
Coupa Software Incorporated
COUP
$76.9M 0.73%
277,655
-227,110
-45% -$45.7M
ADPT icon
41
Adaptive Biotechnologies
ADPT
$3.95B
$76.2M 0.73%
1,574,890
-100,700
-6% -$3.67M
TNET icon
42
TriNet
TNET
$3.15B
$73.9M 0.7%
1,212,038
-178,152
-13% -$8.9M
APO icon
43
Apollo Global Management
APO
$75.8B
$73.4M 0.7%
1,471,000
-232,800
-14% -$10.2M
ENV
44
DELISTED
ENVESTNET, INC.
ENV
$71.5M 0.68%
971,685
-305,835
-24% -$20M
IRTC icon
45
iRhythm Holdings
IRTC
$3.78B
$71M 0.68%
612,585
-73,605
-11% -$8.12M
COR icon
46
Cencora
COR
$62.3B
$70.7M 0.67%
701,500
+80,900
+13% +$7.45M
OPTU
47
Optimum Communications Inc
OPTU
$377M
$66.9M 0.64%
2,968,100
-423,400
-12% -$10.4M
LW icon
48
Lamb Weston
LW
$6.63B
$66.9M 0.64%
1,046,000
+49,325
+5% +$2.98M
SSNC icon
49
SS&C Technologies
SSNC
$19.1B
$66.6M 0.64%
1,179,300
+292,800
+33% +$16M
EME icon
50
Emcor
EME
$33.1B
$65.3M 0.62%
987,350
+34,802
+4% +$2.18M
1
2
3 4 5

Similar funds

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

TimesSquare Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, TimesSquare Capital Management held 245 positions worth $10.5B, up 25% from $8.39B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $429M in Q2 2020, closing 18 positions and reducing 125 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $56.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in Immunomedics Inc worth $64.2M.

  • TimesSquare Capital Management's largest Q2 2020 buy was Immunomedics Inc: 1,811,000 shares worth $64.2M.
  • TimesSquare Capital Management added most to New Relic, Inc. in Q2 2020, an estimated $64.1M increase.
  • TimesSquare Capital Management's biggest Q2 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $120M.
  • TimesSquare Capital Management fully exited Alexion Pharmaceuticals in Q2 2020, selling an estimated $56.2M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.5B portfolio in Q2 2020.
  • TimesSquare Capital Management opened 23 new positions and closed 18 in Q2 2020.
  • TimesSquare Capital Management's portfolio value rose 25% quarter-over-quarter to $10.5B.

Based on TimesSquare Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.